NOVEL CMV PP65 TARGETING DNA VACCINE FOR CANCER IMMUNOTHERAPY
- 专利权人:
- VAXIMM AG
- 发明人:
- Heinz Lubenau
- 申请号:
- US15737679
- 公开号:
- US20180153976A1
- 申请日:
- 2016.06.06
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要:
- The present invention relates to an attenuated strain of Salmonella comprising a DNA molecule encoding CMV pp65. In particular, the present invention relates to the use of said attenuated strain of Salmonella in cancer immunotherapy.
- 来源网站:
- 中国工程科技知识中心